Consolidating Specialist Cardiac Testing

Siemens Healthcare Diagnostics has introduced ADVIA® Chemistry CardioPhase™ hsCRP assay, consolidating specialist cardiac testing onto routine high throughput analysis. The assay is qualified for independent cardiac risk assessment as well as cardiac risk stratification. The results exhibit excellent correlation and similar performance to the industry gold standard method, which is the Siemens BNII™ Nephelometer.

“The availability of this specialist cardiac marker on routine chemistry offers advanced patient care through a convenient and fast hsCRP provision, with maximum confidence in the results,” said Ibti Rashid,

Product Manager for Clinical Chemistry and Automation at Siemens Healthcare Diagnostics.

CardioPhase hsCRP is now available on a broad range of solutions from Siemens, including options for chemistry and immunology laboratories as well as point of care settings.